PR
(주)옴니아메드는 Nitric Oxide 기능을 활용한
치료제 개발에 새로운 패러다임을 열어갑니다.
논문/발표
|
Tumor vasodilation by N-Heterocyclic carbene-based nitric oxide delivery triggered by high-intensity focused ultrasound and enhanced drug homing to tumor sites for anti-cancer therapy
2019-06-21
|
|---|
|
|
